Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular Carcinoma
Background: Hepatocellular carcinoma (HCC) is a lethal malignancy lacking effective treatment. The Cyclin-dependent kinases 4/6 (CDK4/6) and PI3K/AKT signal pathways play pivotal roles in carcinogenesis and are promising therapeutic targets for HCC. Here we identified a new CDK4/6 and PI3K/AKT multi...
Saved in:
Main Authors: | Zhong-Kun Xia (Author), Wei Wang (Author), Jian-Ge Qiu (Author), Xi-Nan Shi (Author), Hong-Jian Li (Author), Rong Chen (Author), Kun-Bin Ke (Author), Chao Dong (Author), Ying Zhu (Author), Shi-Guo Wu (Author), Rong-Ping Zhang (Author), Zhuo-Ran Meng (Author), Hui Zhao (Author), Peng Gu (Author), Kwong-Sak Leung (Author), Man-Hon Wong (Author), Xiao-Dong Liu (Author), Feng-Mei Zhou (Author), Jian-Ying Zhang (Author), Ya-Ting Yao (Author), Si-Jia Wang (Author), Chun-Yang Zhang (Author), Yan-Ru Qin (Author), Marie Chia-mi Lin (Author), Bing-Hua Jiang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinoma
by: Ying Zhu, et al.
Published: (2021) -
CDK12 inhibition upregulates ATG7 triggering autophagy via AKT/FOXO3 pathway and enhances anti-PD-1 efficacy in colorectal cancer
by: Zimei Wu, et al.
Published: (2024) -
Carvacrol Attenuates Diabetic Cardiomyopathy by Modulating the PI3K/AKT/GLUT4 Pathway in Diabetic Mice
by: Ning Hou, et al.
Published: (2019) -
Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin
by: Long Wang, et al.
Published: (2022) -
Sunitinib induced resistance of endothelial cells by up-regulating P-glycoprotein and PI3K/Akt pathway
by: Rong Zhang, et al.
Published: (2022)